Literature DB >> 35405657

Case Report: Histoplasma Hepatitis Presenting as Common Bile Duct Obstruction.

Brittany Hjermstad1, Dale Snover2, Jose D Debes1,2.   

Abstract

Histoplasma capsulatum is the most common endemic mycosis in the United States and can cause disseminated histoplasmosis in immunocompromised patients.1 Although hepatic involvement is common with histoplasmosis, it can be challenging to diagnose. We report a case of a 50-year-old woman receiving adalimumab for rheumatoid arthritis who presented with right upper quadrant pain, fever, jaundice, and dyspnea. The initial working diagnosis was biliary obstruction with potential COVID-19 infection. Endoscopic retrograde cholangiopancreatography suggested Mirizzi syndrome, but successful sphincterotomy failed to improve jaundice over subsequent days. Bronchoscopy and liver biopsy were performed, with the first revealing budding yeast and the later growing H. capsulatum. The patient improved with the initiation of itraconazole therapy.

Entities:  

Year:  2022        PMID: 35405657      PMCID: PMC9209942          DOI: 10.4269/ajtmh.21-1049

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  8 in total

Review 1.  Infectious complications associated with immunomodulating biologic agents.

Authors:  Sophia Koo; Francisco M Marty; Lindsey R Baden
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

2.  A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept.

Authors:  Nina Jain; Jeffrey B Doyon; Jacob E Lazarus; Inga-Marie Schaefer; Melanie E Johncilla; Agoston T Agoston; Anuj K Dalal; Gustavo E Velásquez
Journal:  J Gen Intern Med       Date:  2018-03-12       Impact factor: 5.128

3.  Characterization of the Histoplasma capsulatum-induced granuloma.

Authors:  Erika Heninger; Laura H Hogan; Jozsef Karman; Sinarack Macvilay; Bjork Hill; Jon P Woods; Matyas Sandor
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

Authors:  L Joseph Wheat; Alison G Freifeld; Martin B Kleiman; John W Baddley; David S McKinsey; James E Loyd; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

5.  Granulomatous hepatitis secondary to histoplasma infection after treatment with infliximab.

Authors:  L Barrera; J Alvarez; M Tapias; V Idrovo; R López
Journal:  Case Reports Hepatol       Date:  2013-12-14

6.  Histoplasmosis hepatitis after orthotopic liver transplantation.

Authors:  Laura Washburn; N Thao Galván; Sadhna Dhingra; Abbas Rana; John A Goss
Journal:  J Surg Case Rep       Date:  2017-12-11

Review 7.  Cholestasis and disseminated histoplasmosis in a psoriatic patient on infliximab: case report and review of literature.

Authors:  Steven Park; Janice Cheong; Kaitlin Kyi; Jose Aranez; Sohaib Abu-Farsakh; Christa Whitney-Miller; Bandar Al-Judaibi; Marie Laryea
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

8.  Histoplasmosis presenting as granulomatous hepatitis: case report and review of the literature.

Authors:  Nancy A Rihana; Manasa Kandula; Ana Velez; Kumud Dahal; Edward B O'Neill
Journal:  Case Rep Med       Date:  2014-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.